Michael Gottlieb
Corporate Officer/Principal bij POINT Biopharma, Inc. (United States)
Actieve functies van Michael Gottlieb
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
POINT Biopharma, Inc. (United States)
 POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Corporate Officer/Principal | 01-01-2020 | - |
Loopbaan van Michael Gottlieb
Eerdere bekende functies van Michael Gottlieb
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| POIT BIOP | Corporate Officer/Principal | 01-06-2021 | 25-11-2021 |
Sanofi Canada, Inc.
 Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Canada, Inc. operates as a global biopharmaceutical company. Its products include prescription, non-prescription and vaccines. The company is headquartered in Laval, Canada. | Corporate Officer/Principal | 01-12-2017 | 01-09-2019 |
Opleiding van Michael Gottlieb
| University of Western Ontario | Undergraduate Degree |
| University of Toronto | Graduate Degree |
Statistieken
Internationaal
| Canada | 4 |
| Verenigde Staten | 3 |
Operationeel
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| POIT BIOP | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Commercial Services |
Sanofi Canada, Inc.
Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Canada, Inc. operates as a global biopharmaceutical company. Its products include prescription, non-prescription and vaccines. The company is headquartered in Laval, Canada. | Health Technology |
- Beurs
- Insiders
- Michael Gottlieb
- Ervaring
